1,253 results on '"Miura, Tetsuji"'
Search Results
202. Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
203. Favorable response to an endothelin receptor antagonist in mitomycin-induced pulmonary veno-occlusive disease with pulmonary capillary hemangiomatosis
204. Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy
205. Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
206. Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
207. Successful Transcatheter Diagnosis and Medical Treatment of Right Atrial Involvement in IgG4-related Disease
208. Roles of Intracellular Signaling Pathways Regulating the KATP Channel and Mitochondria in Myocardial Protection from Ischemia/Reperfusion Injury
209. Predictors of appropriate ICD therapy in Japanese patients with structural heart diseases: A major role of prior sustained ventricular tachycardia in secondary prevention
210. Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population
211. Remission of Membranous Nephropathy after Surgical Resection of Benign Cerebellar Meningioma
212. Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts
213. Nutritional Status and Energy Intake as Predictors of Functional Status After Cardiac Rehabilitation in Elderly Inpatients With Heart Failure ― A Retrospective Cohort Study ―
214. Does p53 Inhibition Suppress Myocardial Ischemia–Reperfusion Injury?
215. Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid
216. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication
217. Myocardial Infarction
218. Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus
219. Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats
220. A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
221. Tristetraprolin-mediated Regulation of Rieske, a Mitochondrial Complex III Protein, Protects the Heart Against Iron Deficiency
222. Upregulation of AMP Deaminase in the Vicinity of the SR via Translational Regulation by miR-301b Contributes to Diabetic Cardiomyopathy
223. Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury
224. Abstract P398: Screening of Primary Aldosteronism by Clinical Features and Daily Laboratory Tests: Combination of Urine pH, Sex, and Serum K +
225. Fatty acid-binding protein 5 as a residual risk for atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia
226. Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes
227. Worsening of mitral valve regurgitation after radiofrequency catheter ablation of ventricular arrhythmia originating from a left ventricular papillary muscle
228. Cardiac arrest caused by sibutramine obtained over the Internet: a case of a young woman without pre-existing cardiovascular disease successfully resuscitated using extracorporeal membrane oxygenation
229. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
230. Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
231. Operator Safety Zone During the Nitric Oxide Inhalation Vasoreactivity Test for Pulmonary Hypertension Patients
232. Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study
233. 虚血プレコンディショニングの心筋細胞保護機構とその臨床応用
234. Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes.
235. Novel prediction equation for appendicular skeletal muscle mass estimation in patients with heart failure: Potential application in daily clinical practice
236. Ischaemic conditioning and targeting reperfusion injury : a 30 year voyage of discovery
237. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on 'New frontiers in cardiovascular research'
238. Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells
239. Abstract 13049: Serum FABP5 Concentration, a Novel Determinant of Cholesterol Efflux From Macrophages, is a Potential Biomarker for Residual Risk of Atherosclerosis
240. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
241. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”
242. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease
243. Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic
244. Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
245. The Role of AMP Deaminase in Diabetic Cardiomyopathy and Its Regulatory Mechanisms: A Potential Novel Therapeutic Target
246. Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease–Induced Enlargement of Myocardial Infarct Size
247. Assessment of Both Energy Intake and Nutritional Status Predicts Functional Recovery after Cardiac Rehabilitation in Elderly Inpatients with Heart Failure
248. Aberrant mTORC1 Activation in Cardiomyocytes: A Novel Prognostic Marker and Possible Therapeutic Target in Nonischemic Dilated Cardiomyopathy
249. Is Insulin Resistance or Hyperglycemia Responsible for Abnormality of the Ventricular Repolarization in Diabetic Patients?
250. Prevalence and clinical characteristics of degenerative mitral stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.